$MOS

MOSAIC CO (MOS): Results of Operations and Financial Condition

MOSAIC CO (MOS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 performancedataq22026-ex992.htm EX-99.2 - PERFORMANCE DATA Document Exhibit 99.2 The Mosaic Company Selected Calendar Quarter Financial Information (Unaudited) Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Consolidated data (in millions, except per sha

Original reporting
Published Aug 4, 2026, 8:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MOS
Neutral
medium confidence
Mentioned
$MOS
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MOSNeutralLow
01

Why it matters

The exhibit includes diluted net earnings (loss) per share, adjusted diluted EPS, net sales, operating earnings, cash flow from operations, investing/financing cash flows, and balance-sheet items like net debt. It also breaks out segment contributions for Phosphate and Potash and provides operating data such as tonnes sold and realized costs.

02

Market read

For MOS traders, the most actionable value is trend verification: profitability deterioration in 2025-2026 quarters, cash flow volatility, and rising net debt levels shown in the selected data.

03

What to watch

The excerpt highlights large swings in foreign currency gains/losses and notable items, which can distort headline earnings quality; focus on adjusted EPS, adjusted EBITDA, and operating cash flow trend rather than GAAP EPS alone.

Relevance 7/10Novelty 3/10Timing: filed after market close on 2026-08-04

Background

The Mosaic Company (MOS) submitted an SEC Form 8-K, Item 2.02, attaching Exhibit 99.2 with selected calendar-quarter financial information (unaudited) across multiple quarters from Q3 2024 through Q2 2026.

Company-level read

Ticker impact

$MOSNeutralMedium confidence
Context

Mosaic filed an 8-K with selected quarterly financial information showing diluted EPS swung from $1.04 (Q4 2025) to $0.05 (Q1 2026) and net loss in Q2 2026.

Expected impact

Near-term price impact is likely limited unless traders treat the numbers as a correction versus prior disclosures; otherwise it is more of a reference update.

Evidence & confidence

This is an SEC 8-K exhibit with unaudited selected calendar-quarter data. It contains concrete financial line items (EPS, operating earnings, net cash from operations, net debt) but the excerpt does not show a new guidance change, deal, or regulatory action.

Market effects

Fertilizer producers often trade on margin and cash-flow trends; the exhibit’s segment sales and operating earnings can inform relative positioning, but no new sector catalyst is disclosed.

No region-specific demand or policy catalyst is described in the provided excerpt.

No new global commodity or trade-policy shock is stated; the data is company-specific financial reporting.

Counterpoint

Traders may already have the underlying quarterly results from prior earnings releases, making this 8-K exhibit more of a consolidation than a fresh catalyst.

Key entities

  • The Mosaic Company

    Subject of the SEC 8-K exhibit with selected quarterly financial and segment data.

Related articles

$MOSMed

S&P downgrades Mosaic outlook on high costs, weak cash flow

S&P Global Ratings downgraded Mosaic Co.’s outlook to negative from stable while keeping its BBB issuer credit rating. It expects funds from operations to debt below 20% in 2026. It projects adjusted EBITDA around $1.6B in 2026 vs $2.6B in 2025, citing high sulfur and ammonia costs, weaker phosphate margins, and negative discretionary cash flow of $400M to $500M.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.